Skip to main content
. 2019 Aug 23;11(9):487. doi: 10.3390/toxins11090487

Table 1.

Treatment outcome according to patient characteristics at baseline.

VD Characteristics N Successful Outcome Failed Outcome p Value
VD Subtype Idiopathic VD
Neurogenic VD
80
75
50 (62.5%)
42 (56%)
30 (37.5%)
33 (44%)
0.255
Gender Male
Female
54
99
32 (59.3%)
60 (60.6%)
22 (40.7%)
39 (39.4%)
0.445
Bladder Function DO
DU
DHIC
HSB
57
59
25
14
36 (63.2%)
34 (57.6%)
15 (60%)
7 (50%)
21 (36.8%)
25 (42.4%)
10 (40%)
7 (50%)
0.819
Sphincter Function DV
DSD
PRES
115
237
70 (60.9%)
14 (60.9%)
8 (47.1%)
45 (39.1%)
9 (39.1%)
9 (52.9%)
0.550

VD, voiding dysfunction; DO, detrusor overactivity; DU, detrusor underactivity; DHIC, detrusor hyperreflexia and inadequate contractility; HSB, hypersensitive bladder; DV, dysfunctional voiding; DSD, detrusor sphincter dyssynergia; PRES, poor relaxation of external sphincter.